NO20071618L - Fremgangsmate for screening av antistoffbibliotek - Google Patents

Fremgangsmate for screening av antistoffbibliotek

Info

Publication number
NO20071618L
NO20071618L NO20071618A NO20071618A NO20071618L NO 20071618 L NO20071618 L NO 20071618L NO 20071618 A NO20071618 A NO 20071618A NO 20071618 A NO20071618 A NO 20071618A NO 20071618 L NO20071618 L NO 20071618L
Authority
NO
Norway
Prior art keywords
target groups
members
library
antibody library
screening antibody
Prior art date
Application number
NO20071618A
Other languages
English (en)
Norwegian (no)
Inventor
Marike Josee Janneke G Stassar
Herald Reiersen
Original Assignee
Affitech As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affitech As filed Critical Affitech As
Publication of NO20071618L publication Critical patent/NO20071618L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Semiconductor Lasers (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20071618A 2004-10-08 2007-03-27 Fremgangsmate for screening av antistoffbibliotek NO20071618L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0422431.7A GB0422431D0 (en) 2004-10-08 2004-10-08 Method
PCT/GB2005/003866 WO2006038022A1 (fr) 2004-10-08 2005-10-07 Procedes de criblage de banques d'anticorps

Publications (1)

Publication Number Publication Date
NO20071618L true NO20071618L (no) 2007-06-27

Family

ID=33443626

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071618A NO20071618L (no) 2004-10-08 2007-03-27 Fremgangsmate for screening av antistoffbibliotek

Country Status (22)

Country Link
US (1) US20090081190A1 (fr)
EP (1) EP1800133B1 (fr)
JP (1) JP4564062B2 (fr)
CN (1) CN101052879B (fr)
AT (1) ATE495446T1 (fr)
AU (1) AU2005291012B2 (fr)
BR (1) BRPI0516546A (fr)
CA (1) CA2580080C (fr)
DE (1) DE602005025901D1 (fr)
DK (1) DK1800133T3 (fr)
ES (1) ES2359724T3 (fr)
GB (1) GB0422431D0 (fr)
HK (1) HK1105450A1 (fr)
HR (1) HRP20110234T1 (fr)
IL (1) IL181927A (fr)
NO (1) NO20071618L (fr)
NZ (1) NZ554076A (fr)
PL (1) PL1800133T3 (fr)
RU (1) RU2402777C2 (fr)
SI (1) SI1800133T1 (fr)
WO (1) WO2006038022A1 (fr)
ZA (1) ZA200702527B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009032949A2 (fr) * 2007-09-04 2009-03-12 The Regents Of The University Of California Anticorps d'antigène de cellule souche anti-prostate (psca) à haute affinité pour un ciblage et une détection de cancer
US9079942B2 (en) * 2009-02-09 2015-07-14 Epitomics, Inc. CDR-anchored amplification method
US20100317539A1 (en) * 2009-06-12 2010-12-16 Guo-Liang Yu Library of Engineered-Antibody Producing Cells
US8293483B2 (en) * 2009-09-11 2012-10-23 Epitomics, Inc. Method for identifying lineage-related antibodies
US9567393B2 (en) 2010-10-26 2017-02-14 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University Antibody based reagent that specifically recognizes toxic oligomeric form of beta-amyloid
GB201116364D0 (en) * 2011-09-22 2011-11-02 Bioinvent Int Ab Screening methods and uses thereof
CN106940268B (zh) * 2012-02-23 2021-09-21 朱诺治疗有限公司 细胞和其它复杂生物材料的色谱分离
US9465032B2 (en) * 2012-12-04 2016-10-11 Scinopharm Taiwan Ltd. Method of using antibody-liposome complexes for selecting a pool of molecules
RU2560699C2 (ru) * 2013-08-02 2015-08-20 федеральное государственное автономное образовательное учреждение высшего профессионального образования "Национальный исследовательский ядерный университет МИФИ" (НИЯУ МИФИ) Способ создания наноразмерной диагностической метки на основе конъюгатов наночастиц и однодоменных антител
GB201420852D0 (en) * 2014-11-24 2015-01-07 Genevillage Kft Method
RU2618872C1 (ru) * 2015-12-09 2017-05-11 Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ) Способ направленного истощения олигонуклеотидных библиотек для снижения неспецифической адсорбции при твердофазной селекции аптамеров на основе нуклеиновых кислот
US10526598B2 (en) * 2018-04-24 2020-01-07 Inscripta, Inc. Methods for identifying T-cell receptor antigens
KR102301987B1 (ko) * 2019-11-14 2021-09-13 연세대학교 산학협력단 항체 선별 방법, 박테리아 오염 진단 방법 및 박테리아 오염 진단 키트

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2136092T3 (es) * 1991-09-23 1999-11-16 Medical Res Council Procedimientos para la produccion de anticuerpos humanizados.
US5492807A (en) * 1993-11-19 1996-02-20 Santi; Daniel V. Method of obtaining diagnostic reagents, assays and therapeutics based on clinical manifestations of a disease
US6255455B1 (en) * 1996-10-11 2001-07-03 The Trustees Of The University Of Pennsylvania Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof
TW585921B (en) * 1997-07-10 2004-05-01 Res Dev Foundation Species specific monoclonal antibodies and phage displayed Fab and scFV fragments for fragments for targeted destruction of imported fire ants
US6235686B1 (en) * 2000-08-16 2001-05-22 R.T. Vanderbilt Company, Inc. Lubricating compositions containing aromatized 1,2-dihydro-2,2,4-trimethylquinoline polymers
US20040170955A1 (en) * 2000-09-08 2004-09-02 Wadih Arap Human and mouse targeting peptides identified by phage display
ATE478141T1 (de) * 2000-09-08 2010-09-15 Univ Texas Durch phagendisplay identifizierte zielpeptide des menschen und der maus
US7420030B2 (en) * 2000-09-08 2008-09-02 The Board Of Regents Of The University Of Texas System Aminopeptidase A (APA) targeting peptides for the treatment of cancer
US20040048243A1 (en) * 2001-09-07 2004-03-11 Wadih Arap Methods and compositions for in vitro targeting

Also Published As

Publication number Publication date
HK1105450A1 (en) 2008-02-15
DE602005025901D1 (de) 2011-02-24
EP1800133B1 (fr) 2011-01-12
CA2580080A1 (fr) 2006-04-13
EP1800133A1 (fr) 2007-06-27
ZA200702527B (en) 2008-11-26
JP4564062B2 (ja) 2010-10-20
IL181927A0 (en) 2007-07-04
JP2008516220A (ja) 2008-05-15
CN101052879A (zh) 2007-10-10
DK1800133T3 (da) 2011-03-28
IL181927A (en) 2011-09-27
PL1800133T3 (pl) 2011-06-30
RU2402777C2 (ru) 2010-10-27
GB0422431D0 (en) 2004-11-10
US20090081190A1 (en) 2009-03-26
ATE495446T1 (de) 2011-01-15
RU2007117144A (ru) 2008-11-20
BRPI0516546A (pt) 2008-09-09
NZ554076A (en) 2009-12-24
CA2580080C (fr) 2012-09-18
HRP20110234T1 (hr) 2011-05-31
SI1800133T1 (sl) 2011-06-30
ES2359724T3 (es) 2011-05-26
CN101052879B (zh) 2012-07-25
AU2005291012B2 (en) 2011-04-14
WO2006038022A1 (fr) 2006-04-13
AU2005291012A1 (en) 2006-04-13

Similar Documents

Publication Publication Date Title
NO20071618L (no) Fremgangsmate for screening av antistoffbibliotek
Nesper et al. A novel capture compound for the identification and analysis of cyclic di-GMP binding proteins
Cho et al. Application of saturates, aromatics, resins, and asphaltenes crude oil fractionation for detailed chemical characterization of heavy crude oils by Fourier transform ion cyclotron resonance mass spectrometry equipped with atmospheric pressure photoionization
Rathsack et al. Analysis of high molecular compounds in pyrolysis liquids from a german brown coal by FT-ICR-MS
Byer et al. Distinguishing the C3 vs SH4 mass split by comprehensive two-dimensional gas chromatography–high resolution time-of-flight mass spectrometry
Ortiz et al. Characterization of naphthenic acids by gas chromatography-Fourier transform ion cyclotron resonance mass spectrometry
NZ584684A (en) A method for characterization of a recombinant polyclonal protein
ATE417276T1 (de) Proteinphosphorylierung in t-zellrezeptor- signalwegen
EP2315034A3 (fr) Moyens et procédés d'évaluation du risque d'interventions cardiaques basées sur GDF-15
Kovalchik et al. Standard method design considerations for semi-quantification of total naphthenic acids in oil sands process affected water by mass spectrometry: A review
DK1875239T3 (da) Fremgangsmåde til fremstilling af billeddannelsessonder under anvendelse af klik-kemi
Mladic et al. Rapid screening and identification of ACE inhibitors in snake venoms using at-line nanofractionation LC-MS
AU2018274704A1 (en) Assay for plasma cell associated disease
Luczak et al. Optimization of plasma sample pretreatment for quantitative analysis using iTRAQ labeling and LC-MALDI-TOF/TOF
Echterbille et al. Ion mobility mass spectrometry as a potential tool to assign disulfide bonds arrangements in peptides with multiple disulfide bridges
NO20075285L (no) Fremgangsmate for a bestemme og kontrollere dannelsen av avsetninger i et vannsystem
Rissanen Anthropogenic volatile organic compound (AVOC) autoxidation as a source of highly oxygenated organic molecules (HOM)
Han et al. Characterization of the membrane proteome and N-glycoproteome in BV-2 mouse microglia by liquid chromatography-tandem mass spectrometry
Alsbou et al. Direct infusion mass spectrometric analysis of bio-oil using ESI-Ion-trap MS
WO2009011426A1 (fr) Procédé de criblage utilisant c-met qui est un nouveau substrat pour la γ-sécrétase
Clingenpeel et al. Comprehensive characterization of petroleum acids by distillation, solid phase extraction separation, and Fourier transform ion cyclotron resonance mass spectrometry
WO2009064006A1 (fr) PROCÉDÉ DE CRIBLAGE UTILISANT UN NOUVEAU SUBSTRAT EphA7 POUR LA γ-SECRÉTASE
Schaub et al. Heat-exchanger deposits in an inverted steam-assisted gravity drainage operation. Part 2. Organic acid analysis by electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry
Kang et al. Design and synthesis of new mass tags for matrix-free laser desorption ionization mass spectrometry (LDI-MS) based on 6, 11-dihydrothiochromeno [4, 3-b] indole
DE602006009015D1 (de) ahren zu ihrer Herstellung.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application